A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer,Cancer Biotherapy and Radiopharmaceuticals

当前位置： X-MOL 学术 › Cancer Biother. Radiopharm. › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

A Robust Prognostic Signature of Tumor Microenvironment in Colorectal Cancer
Cancer Biotherapy and Radiopharmaceuticals ( IF 3.4 ) Pub Date : 2022-12-12 , DOI: 10.1089/cbr.2021.0171
Jingwen Liu _{1,

2,

3} , Fei Yu ₄ , Zhao Liu ₅ , Xiaojing Wang _{6,

7} , Jianming Li _{1,

2,

3}

Affiliation

Background: Colorectal cancer (CRC) has been a major public health problem. Tumor microenvironment (TME) greatly contributes to the heterogeneity of CRC and is crucial for the regulation of CRC progression. The authors' study aimed to develop a robust prognostic signature for CRC patients based on TME-related genes.

中文翻译：